PD-L1 x ABCG2

N/A

Report date: 2025/01/26 17:44:27

Base Information

Drug NamePD-L1 x ABCG2
Drug Alias NameAnti-PD-L1/BCRP efflux pump bispecific antibody (Kenjockety Biotechnology)anti-ABCG2 efflux pump/PD-L1 checkpoint inhibitor bispecific antibody (Kenjockety Biotechnology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionProgrammed death-ligand 1 blockersBroad substrate specificity ATP-binding cassette transporter ABCG2 inhibitors
TargetsProgrammed death-ligand 1Broad substrate specificity ATP-binding cassette transporter ABCG2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKenjockety Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesKenjockety Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A